デフォルト表紙
市場調査レポート
商品コード
1593461

ライフサイエンスツール市場規模、シェア、成長分析、製品別、技術別、最終用途別、地域別 - 産業予測、2024年~2031年

Life Science Tool Market Size, Share, Growth Analysis, By Product, By Technology, By End-use, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 248 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ライフサイエンスツール市場規模、シェア、成長分析、製品別、技術別、最終用途別、地域別 - 産業予測、2024年~2031年
出版日: 2024年11月10日
発行: SkyQuest
ページ情報: 英文 248 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ライフサイエンスツールの世界市場規模は、2022年に1,440億9,000万米ドルと評価され、2023年の1,596億7,000万米ドルから2031年には3,629億5,000万米ドルに成長し、予測期間中(2024年~2031年)のCAGRは10.81%で成長する見通しです。

生物科学を包含する生命科学は、人間や動物を含む生物の理解を深める上で極めて重要な役割を果たしています。この分野は、物理科学と並ぶ自然科学の基礎であり、細胞生物学、バイオテクノロジー、遺伝学、生化学など様々な学問分野を統合しています。ライフサイエンスツール市場は広大で、健康、医学、農業、製薬、食品科学にわたるプロセスを促進する多様な分析ツール、機器、消耗品、試薬を提供しています。ライフサイエンス研究から生まれるイノベーションは、新しい治療法や高度な医療技術の開発を通じて人間の健康を改善するだけでなく、疾病メカニズムの理解を深める。さらに、生命科学は環境問題や生物多様性に関する重要な洞察を提供し、地球を保護する努力を促進しています。このような貢献を念頭に、米国のライフサイエンスツール市場は、高度な分析ソリューションに対する継続的な需要と、健康状態の改善という急務に牽引され、次予測年度には持続可能なCAGRで力強い成長を遂げると予測されます。この成長軌道は、健康に関連する課題と、より広範な環境への配慮の両方への取り組みにおけるライフサイエンスの重要性を強調するものであり、同市場を医療と自然保護の両方の未来を形作る重要なプレーヤーとして位置づけています。

目次

イントロダクション

  • 調査の目的
  • 定義
  • 市場範囲

調査手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模予測
  • 市場の想定と制限

エグゼクティブサマリー

  • 市場概要見通し
  • 供給需要動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主な市場の考察

  • 主な成功要因
  • 競合の程度
  • 主な投資機会
  • 市場のエコシステム
  • バリューチェーン分析
  • サプライチェーン分析
  • 特許分析
  • 貿易分析
  • 技術分析
  • 規制情勢
  • 価格分析

ライフサイエンスツール市場:製品別

  • 市場概要
  • 細胞培養システムと3D細胞培養
  • 液体クロマトグラフィー
  • 質量分析
  • フローサイトメトリー
  • クローニングとゲノム工学
    • キット試薬消耗品
    • サービス
  • 顕微鏡検査と電子顕微鏡検査
  • 次世代シーケンシング
  • PCRとqPCR
  • 核酸調製
  • 核酸マイクロアレイ
  • サンガーシーケンス
  • トランスフェクションデバイスと遺伝子送達技術
    • 装置
    • 試薬
  • 核磁気共鳴
  • その他の分離技術
  • その他の製品とサービス
    • 抗体
    • 一般用品
    • その他

ライフサイエンスツール市場:技術別

  • 市場概要
  • ゲノム技術
  • プロテオミクス技術
  • 細胞生物学技術
  • ラボ用品とテクノロジー
  • その他の分析およびサンプル調製技術

ライフサイエンスツール市場:用途別

  • 市場概要
  • 政府と学術機関
  • バイオ医薬品会社
  • ヘルスケア
  • 産業用途
  • その他

ライフサイエンスツール市場:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • Merck KGaA
  • Shimadzu Corporation
  • Hitachi, Ltd.
  • Bruker Corporation
  • Oxford Instruments plc
  • Zeiss International
  • Revvity Inc
  • Eppendorf AG
  • Sartorius AG
  • Lonza Group AG
  • Waters Corporation
目次
Product Code: SQSG35J2006

Global Life Science Tool Market size was valued at USD 144.09 billion in 2022 and is poised to grow from USD 159.67 billion in 2023 to USD 362.95 billion by 2031, growing at a CAGR of 10.81% during the forecast period (2024-2031).

The life sciences, encompassing biological sciences, play a pivotal role in enhancing our understanding of living organisms, including humans and animals. This field, a foundational aspect of Natural Science alongside Physical Science, integrates various disciplines such as cell biology, biotechnology, genetics, and biochemistry. The life sciences tools market is expansive, offering a diverse range of analytical tools, equipment, supplies, and reagents that facilitate processes across health, medicine, agriculture, pharmaceuticals, and food science. The innovations stemming from life sciences research not only improve human health through the development of new treatments and advanced medical technologies but also enhance our comprehension of disease mechanisms. Additionally, life sciences provide critical insights into environmental issues and biodiversity, fostering efforts to protect the planet. With these contributions in mind, the US Life Science Tools Market is projected to experience robust growth at a sustainable compound annual growth rate (CAGR) in the upcoming forecast year, driven by the ongoing demand for advanced analytical solutions and the imperative for improved health outcomes. This growth trajectory underscores the importance of life sciences in addressing both health-related challenges and broader environmental considerations, positioning the market as a key player in shaping the future of both medicine and conservation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Life Science Tool market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Life Science Tool Market Segmental Analysis

Global Life Science Tool Market is segmented by Product, Technology, End-use, and Region. Based on Product, the market is segmented into Cell Culture Systems & 3D Cell Culture, Liquid Chromatography, Mass Spectrometry, Flow Cytometry, Cloning & Genome Engineering (Kits, Reagents, and Consumables, Services), Microscopy & Electron Microscopy, Next Generation Sequencing, PCR & qPCR, Nucleic Acid Preparation, Nucleic Acid Microarray, Sanger Sequencing , Transfection Devices & Gene Delivery Technologies (Equipment, Reagents), NMR, Other Separation Technologies, Other Products & Services (Antibodies, General Supplies, Others). Based on Technology, the market is segmented into Genomic Technology, Proteomics Technology. Cell Biology Technology, Lab Supplies & Technologies, Other Analytical & Sample Preparation Technology. Based on End-use, the market is segmented into Government & Academic, Biopharmaceutical Company, Healthcare, Industrial Applications, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Life Science Tool Market

The Global Life Science Tool market is experiencing robust growth driven by rapid technological advancements in sequencing technologies, mass spectrometry, NMR, chromatography, and other analytical methods. Increased investment in research and development by market players, coupled with a surge in strategic partnerships and innovations, significantly propels market expansion. The flurry of acquisitions within the life sciences and biopharma sectors in 2020 has set the stage for accelerated growth in subsequent years, as more companies enhance their capabilities across the biological production value chain. This evolving landscape empowers a diverse range of players, thereby significantly fueling the overall market development.

Restraints in the Global Life Science Tool Market

The Global Life Science Tool market faces significant restraints due to several factors that hinder widespread adoption and implementation. The high costs associated with life science software implementation can deter smaller institutions and research facilities from investing in necessary tools, limiting overall market growth. Additionally, the complex programming required for effective utilization presents a steep learning curve, further complicating user adoption. The necessity for additional infrastructural support and accompanying data management expenses can strain budgets, particularly for organizations with constrained resources. These combined challenges create a barrier to entry, preventing equitable access to advanced life science tools across the industry.

Market Trends of the Global Life Science Tool Market

The Global Life Science Tool market is poised for significant growth, bolstered by comparatively streamlined approval processes compared to pharmaceuticals and medical devices. This trend facilitates the rapid introduction of a diverse array of life science tools, essential for addressing the rising prevalence of infectious diseases. These instruments play a pivotal role in disease identification, comprehension, and monitoring, thus driving market demand. Furthermore, continuous technological advancements and enhancements in the production capabilities of life science tools are expected to contribute to market expansion. Collectively, these factors position the Life Science Tool market for a robust upward trajectory in the coming years.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Value Chain Analysis
  • Supply Chain Analysis
  • Patent Analysis
  • Trade Analysis
  • Technology Analysis
  • Regulatory Landscape
  • Pricing Analysis

Life Science Tool Market, By Product

  • Market Overview
  • Cell Culture Systems & 3D Cell Culture
  • Liquid Chromatography
  • Mass Spectrometry
  • Flow Cytometry
  • Cloning & Genome Engineering
    • Kits, Reagents, and Consumables
    • Services
  • Microscopy & Electron Microscopy
  • Next Generation Sequencing
  • PCR & qPCR
  • Nucleic Acid Preparation
  • Nucleic Acid Microarray
  • Sanger Sequencing
  • Transfection Devices & Gene Delivery Technologies
    • Equipment
    • Reagents
  • NMR
  • Other Separation Technologies
  • Other Products & Services
    • Antibodies
    • General Supplies
    • Others

Life Science Tool Market, By Technology

  • Market Overview
  • Genomic Technology
  • Proteomics Technology
  • Cell Biology Technology
  • Lab Supplies & Technologies
  • Other Analytical & Sample Preparation Technology

Life Science Tool Market, By End-use

  • Market Overview
  • Government & Academic
  • Biopharmaceutical Company
  • Healthcare
  • Industrial Applications
  • Others

Life Science Tool Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Agilent Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Illumina, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hitachi, Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Instruments plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zeiss International
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revvity Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eppendorf AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Waters Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments